EMCURE PHARMACEUTICALS
Back to Income Statement
|
EMCURE PHARMACEUTICALS Last 5 Year Operating Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Operating Profit (Excl OI) | ₹1,469 Cr | ₹1,230 Cr | ₹1,181 Cr | ₹1,330 Cr | ₹1,232 Cr |
What is the latest Operating Profit of EMCURE PHARMACEUTICALS ?
| Year | Operating Profit |
|---|---|
| Mar2026 | ₹1,469 Cr |
| Mar2025 | ₹1,230 Cr |
| Mar2024 | ₹1,181 Cr |
| Mar2023 | ₹1,330 Cr |
| Mar2022 | ₹1,232 Cr |
How is Operating Profit of EMCURE PHARMACEUTICALS Trending?
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,469 Cr | 19.45 | |
| Mar2025 | ₹1,230 Cr | 4.11 | |
| Mar2024 | ₹1,181 Cr | -11.18 | |
| Mar2023 | ₹1,330 Cr | 7.95 | |
| Mar2022 | ₹1,232 Cr | - | |
Compare Operating Profit of peers of EMCURE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EMCURE PHARMACEUTICALS | ₹35,570.6 Cr | 6.8% | -4% | 29.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹422,283.0 Cr | 0.9% | -5% | 3.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹251,611.0 Cr | 3.6% | -1.4% | 37.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹175,182.0 Cr | 1.7% | -6.7% | 28% | Stock Analytics | |
| CIPLA | ₹109,063.0 Cr | 2.8% | -3.9% | -17.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,926.0 Cr | 5.4% | 8.7% | 1.6% | Stock Analytics | |
EMCURE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EMCURE PHARMACEUTICALS | 6.8% |
-4% |
29.4% |
| SENSEX | -0.3% |
-1.6% |
-12.3% |
You may also like the below Video Courses